Caxton Associates (New York)’s Chemed CHE Stock Holding History

Caxton Associates (New York)’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-7,083	Closed	-$3.84M	–	430
2023 Q2	$3.84M	Buy	7,083 +4,564	+181%	+$2.49M	0.57%	21
2023 Q1	$1.35M	Buy	+2,519	New	+$1.28M	0.2%	99
2020 Q4	–	Sell	-477	Closed	-$229K	–	162
2020 Q3	$229K	Buy	+477	New	+$234K	0.02%	240
2020 Q2	–	Sell	-812	Closed	-$352K	–	476
2020 Q1	$352K	Sell	812 -131	-14%	-$58.5K	0.06%	227
2019 Q4	$414K	Buy	943 +151	+19%	+$63.5K	0.06%	212
2019 Q3	$331K	Buy	+792	New	+$323K	0.07%	238
2019 Q2	–	Sell	-1,470	Closed	-$471K	–	411
2019 Q1	$471K	Sell	1,470 -1,449	-50%	-$445K	0.07%	157
2018 Q4	$827K	Hold	2,919	–	–	0.13%	72
2018 Q3	$933K	Buy	2,919 +767	+36%	+$244K	0.06%	153
2018 Q2	$693K	Buy	+2,152	New	+$673K	0.04%	210
2017 Q4	–	Sell	-2,732	Closed	-$552K	–	356
2017 Q3	$552K	Hold	2,732	–	–	0.02%	302
2017 Q2	$559K	Buy	+2,732	New	+$544K	0.02%	301

Other funds holding CHE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Caxton Associates (New York)'s CHE Position: Q3 2023 in Review

Caxton Associates (New York) sold out of Chemed (CHE) in Q3 2023, closing a stake of 7,083 shares — an estimated $3.84M sold.

Caxton Associates (New York) first reported a position in CHE in Q2 2017 and held it in 12 quarters. The position peaked at $3.84M in Q2 2023. 457 funds tracked by Wall St. Rank hold CHE as of Q3 2023.

Caxton Associates (New York) reported no remaining Chemed position as of Q3 2023 after selling out during the quarter.
Caxton Associates (New York) sold 7,083 Chemed shares in Q3 2023, an estimated $3.84M.
Caxton Associates (New York) first reported a position in Chemed in Q2 2017 and held it in 12 quarters.
Caxton Associates (New York)'s Chemed position peaked at $3.84M in Q2 2023.
457 funds tracked by Wall St. Rank held Chemed as of Q3 2023.

Based on Caxton Associates (New York)'s 13F filing for Q3 2023, filed 14 Nov 2023.